Q2 2022 Holdings
Filed 2022-08-11 | 214 holdings | $971.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $154.3M | 1,058,186 | 15.9% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $143.5M | 3,850,171 | 14.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $90.1M | 4,062,792 | 9.3% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $89.4M | 2,124,276 | 9.2% |
| Caredx Inc(CDNA) | COM | 14167L103 | $54.5M | 2,537,524 | 5.6% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $49.4M | 231,069 | 5.1% |
| Centene Corp del(CNC) | COM | 15135B101 | $46.2M | 545,903 | 4.8% |
| BIO RAD Labs Inc(BIO) | CL A | 090572207 | $45.1M | 91,161 | 4.6% |
| Align Technology Inc(ALGN) | COM | 016255101 | $32.0M | 135,240 | 3.3% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $31.3M | 817,141 | 3.2% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $28.6M | 3,539,055 | 2.9% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $26.8M | 2,671,413 | 2.8% |
| Atricure Inc(ATRC) | COM | 04963C209 | $26.2M | 641,896 | 2.7% |
| Celldex Therapeutics(CLDX) | COM NEW | 15117B202 | $24.9M | 925,000 | 2.6% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $22.5M | 151,200 | 2.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $22.2M | 572,621 | 2.3% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $20.7M | 941,059 | 2.1% |
| Avantor Inc(AVTR) | COM | 05352A100 | $15.6M | 503,007 | 1.6% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $12.2M | 933,803 | 1.3% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $11.6M | 4,717,113 | 1.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $6.1M | 73,753 | 0.6% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.5M | 21,850 | 0.5% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $2.6M | 66,400 | 0.3% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $2.3M | 90,100 | 0.2% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $1.4M | 84,400 | 0.1% |
| Arcturus Therapeutics Hldgs(ARCT) | COM | 03969T109 | $623.0K | 39,550 | 0.1% |
| Caribou Biosciences Inc(CRBU) | COM | 142038108 | $382.0K | 70,300 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $361.9K | 9,776,528 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $331.4K | 1,176,136 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $277.3K | 2,844,305 | 0.0% |
| Moderna Inc(MRNA) | COM | 60770K107 | $225.3K | 1,577,351 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $210.7K | 2,773,377 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $191.2K | 3,349,379 | 0.0% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $182.5K | 909,348 | 0.0% |
| Abbott Labs(ABT) | COM | 002824100 | $171.0K | 1,573,807 | 0.0% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $155.1K | 302,044 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $143.2K | 917,907 | 0.0% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $131.1K | 2,313,852 | 0.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $124.0K | 808 | 0.0% |
| Elevance Health Inc(ELV) | COM | 036752103 | $100.6K | 208,500 | 0.0% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $96.1K | 1,010,627 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $96.0K | 2,973,178 | 0.0% |
| Stryker Corporation(SYK) | COM | 863667101 | $95.0K | 477,634 | 0.0% |
| Danaher Corporation(DHR) | COM | 235851102 | $92.3K | 364,036 | 0.0% |
| Radius Health Inc | COM NEW | 750469207 | $91.2K | 8,796,538 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $88.0K | 3,550,086 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $85.4K | 1,139,455 | 0.0% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $84.6K | 342,982 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $84.2K | 386,335 | 0.0% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $80.2K | 2,887,259 | 0.0% |